Document 1813
 DOCN  M94A1813
 TI    Validation and implementation of a HIV+ patient (P) cluster in an acute
       care setting.
 DT    9412
 AU    Kenyon VS; Shumaker RL; Woods JP; Ricchezza CE; Yangco BG; Infectious
       Disease Research Institute, Tampa, FL 33614.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):445 (abstract no. PD0387). Unique
       Identifier : AIDSLINE ICA10/94370762
 AB    OBJECTIVE: To open: a HIV+ P. Cluster. METHODS/RESULTS: In July 1992
       Hospital Departments interested and affected by the HIV+ population
       formed a Task Force (TF). The anticipated outcome was to submit a
       proposal to administration to validate the clustering of this P
       population and the anticipated expectations. Data aggregation included a
       review of the literature, P population surveillance, assessment of
       structural and staffing needs, and discussion and direction regarding
       medical staff affairs and public relations. In December the proposal to
       open a 10 bed unit March of 1993 was approved by administration. In the
       interim, the TF expanded with the goal of developing a business plan to
       be submitted to the Executive team and structural renovations to the
       unit were completed. The unit opened 3/93 and expanded to 20 beds 1/94.
       A SWOT (strength/weakness/opportunity/threat) analysis and mission
       values directed the TF efforts. The TF divided into an Advisory
       Committee and an Executive Steering Committee. Tools are being developed
       to assess this method for development of P population clusters. Average
       Length of Stay (LOS) is 9.9 days compared to a baseline of 13.7.
       CONCLUSION: When presented with a well structured plan administration
       may be receptive to and supportive of clustering HIV+ P. LOS decreased.
       On-going analysis will provide budget comparisons. Baseline data should
       be developed to evaluate patient satisfaction.
 DE    Hospital Units/*ORGANIZATION & ADMIN  Human  *HIV Seropositivity
       MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).